JP2016520656A - コルチコステロイド組成物 - Google Patents

コルチコステロイド組成物 Download PDF

Info

Publication number
JP2016520656A
JP2016520656A JP2016518385A JP2016518385A JP2016520656A JP 2016520656 A JP2016520656 A JP 2016520656A JP 2016518385 A JP2016518385 A JP 2016518385A JP 2016518385 A JP2016518385 A JP 2016518385A JP 2016520656 A JP2016520656 A JP 2016520656A
Authority
JP
Japan
Prior art keywords
propylene glycol
glyceryl
glycol
acetate
fatty acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2016518385A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016520656A5 (enExample
Inventor
ラスロップ ロバート
ラスロップ ロバート
ウェイド オズボーン デイビッド
ウェイド オズボーン デイビッド
Original Assignee
トルマー，インコーポレイティド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by トルマー，インコーポレイティド filed Critical トルマー，インコーポレイティド
Publication of JP2016520656A publication Critical patent/JP2016520656A/ja
Publication of JP2016520656A5 publication Critical patent/JP2016520656A5/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dispersion Chemistry (AREA)
  • Transplantation (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
JP2016518385A 2013-06-03 2014-06-02 コルチコステロイド組成物 Pending JP2016520656A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361830531P 2013-06-03 2013-06-03
US61/830,531 2013-06-03
PCT/US2014/040560 WO2014197398A1 (en) 2013-06-03 2014-06-02 Corticosteroid compositions

Publications (2)

Publication Number Publication Date
JP2016520656A true JP2016520656A (ja) 2016-07-14
JP2016520656A5 JP2016520656A5 (enExample) 2017-07-13

Family

ID=51014660

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016518385A Pending JP2016520656A (ja) 2013-06-03 2014-06-02 コルチコステロイド組成物

Country Status (10)

Country Link
US (2) US10111956B2 (enExample)
EP (1) EP3003272A1 (enExample)
JP (1) JP2016520656A (enExample)
CN (1) CN105263474A (enExample)
AR (1) AR096459A1 (enExample)
AU (1) AU2014275195A1 (enExample)
CA (1) CA2912873A1 (enExample)
HK (1) HK1223300A1 (enExample)
MX (1) MX2015016603A (enExample)
WO (1) WO2014197398A1 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2021504468A (ja) * 2017-11-27 2021-02-15 ウメクリン コグニチオン アーべー ３α−エチニル−３β−ヒドロキシアンドロスタン−１７−オンオキシムの医薬製剤

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9364485B2 (en) 2009-08-31 2016-06-14 Dr. Reddy's Laboratories Ltd. Topical formulations comprising a steroid
US20160184431A1 (en) 2014-03-11 2016-06-30 Promius Pharma Llc Topical compositions comprising a corticosteroid
ES2857602T3 (es) * 2014-03-11 2021-09-29 Promius Pharma Llc Composiciones tópicas de corticosteroides
ITUB20153490A1 (it) * 2015-09-08 2017-03-08 Novamont Spa Miscele di esteri dell?acido pelargonico
ITUB20153463A1 (it) 2015-09-08 2017-03-08 Novamont Spa Composizioni cosmetiche a base di polveri contenenti esteri dell?acido pelargonico
ITUB20153460A1 (it) * 2015-09-08 2017-03-08 Novamont Spa Composizioni cosmetiche acquose contenenti esteri dell?acido pelargonico
ITUB20153461A1 (it) 2015-09-08 2017-03-08 Novamont Spa Composizioni cosmetiche lipofile contenenti esteri dell?acido pelargonico
US20190008969A1 (en) * 2017-07-06 2019-01-10 Tioga Research, Inc. Compositions for drug delivery
CN111904932B (zh) * 2019-05-08 2023-06-20 北京德立福瑞医药科技有限公司 一种含有糖皮质激素的胶束制剂及其制备方法
CN117881411A (zh) 2021-06-01 2024-04-12 艾迪雅生物有限责任公司 用于眼部药物的延长释放药物递送系统和使用方法
EP4344696A4 (en) * 2021-06-30 2025-07-09 D Nature Co Ltd FUNCTIONAL COMPOSITION FOR ALOPECIA COMPRISING AN EXTRACT DERIVED FROM CENTIPEDA MINIMA

Citations (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1048820A (en) * 1963-05-29 1966-11-23 Merck & Co Inc Emollient compositions containing liquid fatty acid esters
US4305936A (en) * 1980-10-09 1981-12-15 Dermik Laboratories Topical corticosteroid formulations
JPH01165529A (ja) * 1987-11-23 1989-06-29 Alza Corp 皮膚透過促進剤としてグリセロールモノオレエートを用いる治療系
JPH04226922A (ja) * 1990-05-17 1992-08-17 Bristol Myers Squibb Co コントロール可能な皮膚浸透用局所組成物
JPH06256218A (ja) * 1993-03-04 1994-09-13 Lederle Japan Ltd 外用剤
JP2001505544A (ja) * 1996-09-11 2001-04-24 ティロッツ・ファルマ・アクチエンゲゼルシャフト フルオシノニド含有経口組成物
JP2001233772A (ja) * 2000-02-23 2001-08-28 Taiho Yakuhin Kogyo Kk 外用剤組成物
JP2002029965A (ja) * 2000-06-16 2002-01-29 Pacific Corp 親水性または塩の形態よりなる薬物を含有する経皮投与用製剤
JP2002519318A (ja) * 1998-06-26 2002-07-02 エルデイエス・テクノロジーズ・インコーポレーテツド 鼻および肺送達のためのコルチコステロイドを含有する水性組成物
US6512010B1 (en) * 1996-07-15 2003-01-28 Alza Corporation Formulations for the administration of fluoxetine
JP2003506462A (ja) * 1999-06-25 2003-02-18 ダーハム ファーマシューティカルズ リミテッド 皮膚浸透剤を含む局所処方物およびその使用
JP2007526885A (ja) * 2003-07-07 2007-09-20 ネアーズ エービー マイクロエマルジョンおよび気道疾患を防ぐためのその使用
US20070264344A1 (en) * 2006-03-15 2007-11-15 Galderma S.A. Topically applicable anti-inflammatory O/W emulsions comprising pro-penetrating glycols
JP2007533697A (ja) * 2004-04-22 2007-11-22 デュオコート エービー グルココルチコイド救急治療用の医薬組成物
JP2008522997A (ja) * 2004-12-09 2008-07-03 バイエル・ヘルスケア・アクチェンゲゼルシャフト 酸によるグルココルチコイドエステルの安定化
JP2008533052A (ja) * 2005-03-10 2008-08-21 スリーエム イノベイティブ プロパティズ カンパニー 抗ウイルス性組成物および使用方法
JP2009504619A (ja) * 2005-08-11 2009-02-05 ガルデルマ・ソシエテ・アノニム 皮膚科学における局所適用用水中油型エマルション
JP2010514748A (ja) * 2006-12-29 2010-05-06 アーダナ バイオサイエンス リミテッド 組成物の調製方法
WO2011154004A1 (en) * 2010-06-11 2011-12-15 Leo Pharma A/S A pharmaceutical spray composition comprising a vitamin d analogue and a corticosteroid
CN102940594A (zh) * 2012-12-04 2013-02-27 艾能赛克机械设备(江苏)有限公司 一种头发调理剂
WO2013076160A1 (en) * 2011-11-21 2013-05-30 Université Libre de Bruxelles Sustained release formulations useful in the treatment of diseases

Family Cites Families (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994013257A1 (en) 1992-12-16 1994-06-23 Creative Products Resource Associates, Ltd. Occlusive/semi-occlusive lotion for treatment of a skin disease or disorder
US6113921A (en) 1993-03-23 2000-09-05 Pharmos Corp. Topical and transdermal delivery system utilizing submicron oil spheres
GB9311132D0 (en) 1993-05-28 1993-07-14 Eisai London Res Lab Ltd Control of cell death
US5989536A (en) 1993-07-03 1999-11-23 The Procter & Gamble Company Personal cleansing compositions containing alkoxylated ether and cationic ammonium salt for deposition of active agent upon the skin
EP0748203A1 (en) 1994-03-11 1996-12-18 The Procter & Gamble Company LOW pH, HYDROLYTICALLY STABLE, COSMETIC COMPOSITIONS CONTAINING ACIDIC ACTIVES
US6300326B1 (en) 1994-11-02 2001-10-09 Michael R. Dobbs Composition and method for control and treatment of cutaneous inflammation
AU4472396A (en) * 1994-12-30 1996-07-24 American Home Products Corporation Clear non-alcoholic hydrocortisone solutions
GB9504265D0 (en) 1995-03-03 1995-04-19 Medeva Plc Corticosteroid-containing pharmaceutical composition
US5948416A (en) 1995-06-29 1999-09-07 The Procter & Gamble Company Stable topical compositions
US5756014A (en) 1997-04-11 1998-05-26 Igen, Inc. Heat resistant lipid vesicles
US6066292A (en) 1997-12-19 2000-05-23 Bayer Corporation Sterilization process for pharmaceutical suspensions
US5972920A (en) 1998-02-12 1999-10-26 Dermalogix Partners, Inc. Formulation containing a carrier, active ingredient, and surfactant for treating skin disorders
EP1085913A1 (en) 1998-06-08 2001-03-28 Ferris Corporation Analgesic and antinociceptive methods
US6723714B2 (en) 1999-07-06 2004-04-20 Blansett Pharmacal Co., Inc. Aqueous solvent for corticosteroids
US6843983B2 (en) 2001-06-07 2005-01-18 Virgie Bright-Ellington Shaving preparations and methods for the prevention and treatment of pseudofolliculitis barbae
US6765001B2 (en) 2001-12-21 2004-07-20 Medicis Pharmaceutical Corporation Compositions and methods for enhancing corticosteroid delivery
US20060140984A1 (en) 2002-10-25 2006-06-29 Foamix Ltd. Cosmetic and pharmaceutical foam
US7704518B2 (en) 2003-08-04 2010-04-27 Foamix, Ltd. Foamable vehicle and pharmaceutical compositions thereof
US7700076B2 (en) 2002-10-25 2010-04-20 Foamix, Ltd. Penetrating pharmaceutical foam
US20070292359A1 (en) 2002-10-25 2007-12-20 Foamix Ltd. Polypropylene glycol foamable vehicle and pharmaceutical compositions thereof
US20080031907A1 (en) 2002-10-25 2008-02-07 Foamix Ltd. Cosmetic and pharmaceutical foam
US20070292461A1 (en) 2003-08-04 2007-12-20 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
US20080206161A1 (en) 2002-10-25 2008-08-28 Dov Tamarkin Quiescent foamable compositions, steroids, kits and uses thereof
US9265725B2 (en) 2002-10-25 2016-02-23 Foamix Pharmaceuticals Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
US7820145B2 (en) 2003-08-04 2010-10-26 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
US7981877B2 (en) 2003-01-23 2011-07-19 Patel Pravin M Stabilized steroid composition and method for its preparation
US7378405B2 (en) 2003-01-23 2008-05-27 Triax Pharmaceuticals, Llc Stabilized steroid composition and method for its preparation
US7186416B2 (en) 2003-05-28 2007-03-06 Stiefel Laboratories, Inc. Foamable pharmaceutical compositions and methods for treating a disorder
US20060018852A1 (en) 2003-08-22 2006-01-26 L'oreal Compositions containing topical active agents and pentylene glycol
US20050043283A1 (en) 2003-08-22 2005-02-24 L'oreal S.A. Compositions containing topical active agents and pentylene glycol
US9314431B2 (en) 2005-02-14 2016-04-19 Transdermal Corp Solubilized benzoyl small molecule
US20070027152A1 (en) 2005-07-27 2007-02-01 Clark Kathleen L Topical anti-pruritic compositions and methods of action of same
US7666859B2 (en) 2006-09-08 2010-02-23 Norman Turkowitz Skin compositions containing hydrocortisone
US20180353413A9 (en) 2006-09-08 2018-12-13 Norman Turkowitz Skin compositions containing hydrocortisone
FR2911781B1 (fr) * 2007-01-26 2009-03-20 Fabre Pierre Dermo Cosmetique Emulsion dermatologique et procede de preparation
US20090088413A1 (en) 2007-09-27 2009-04-02 Burkenstock Sr Bruce Pharmaceutical composition for topical application
GB0720716D0 (en) 2007-10-23 2007-12-05 York Pharma Plc Novel formulation
US20090181068A1 (en) 2008-01-14 2009-07-16 Dunn Richard L Low Viscosity Liquid Polymeric Delivery System
US20090233892A1 (en) 2008-03-11 2009-09-17 Glenmark Generics Ltd Topical Compositions Comprising Hydrocortisone Butyrate
US20110308985A1 (en) 2009-02-26 2011-12-22 Gina Van Bogaert Composition of a liposomal gel containing hydrocortisone, its metabolites, precursors or mixtures thereof and the use thereof
EP2411014A2 (en) 2009-03-25 2012-02-01 Vanangamudi, Sulur Subramaniam A medicinal steroids cream and a process to make it
US20120270835A1 (en) 2009-04-13 2012-10-25 Apex Laboratories Private Limited Medicinal Cream Made Using Hydrocortisone Acetate and A Process To Make The Same
WO2010122452A1 (en) 2009-04-20 2010-10-28 Sulur Subramaniam Vanangamudi A medicinal antifungal and steroid cream incorporating a biopolymer and a process to make it
WO2010122453A1 (en) 2009-04-20 2010-10-28 Sulur Subramaniam Vanangamudi A medicinal cream containing miconazole nitrate, hydrocortisone acetate, and a biopolymer, and a process to make it
US20110269726A1 (en) 2010-04-30 2011-11-03 Valerie Goldburt Method of and system for treatment of inflammatory skin conditions
US8809307B2 (en) 2010-11-22 2014-08-19 Dow Pharmaceutical Sciences, Inc. Pharmaceutical formulations containing corticosteroids for topical administration
EP2709632A4 (en) 2011-05-16 2015-03-04 Dale L Pearlman COMPOSITIONS AND METHOD FOR THE TREATMENT OF SKIN DISEASES
US20140234227A1 (en) 2011-10-10 2014-08-21 Otic Pharma Ltd. Foam formulations
US8580286B2 (en) 2012-03-16 2013-11-12 Dale L. Pearlman Compositions and methods for the treatment of skin diseases
KR101457789B1 (ko) * 2013-02-13 2014-11-03 동아제약 주식회사 상처 치료용 필름형성 약제학적 조성물 및 그의 제조방법
KR20150122719A (ko) 2013-02-28 2015-11-02 프리시전 더마톨로지, 인크. 증진된 생체이용률을 갖는 코르티코스테로이드의 국소 제제

Patent Citations (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1048820A (en) * 1963-05-29 1966-11-23 Merck & Co Inc Emollient compositions containing liquid fatty acid esters
US4305936A (en) * 1980-10-09 1981-12-15 Dermik Laboratories Topical corticosteroid formulations
JPH01165529A (ja) * 1987-11-23 1989-06-29 Alza Corp 皮膚透過促進剤としてグリセロールモノオレエートを用いる治療系
JPH04226922A (ja) * 1990-05-17 1992-08-17 Bristol Myers Squibb Co コントロール可能な皮膚浸透用局所組成物
JPH06256218A (ja) * 1993-03-04 1994-09-13 Lederle Japan Ltd 外用剤
US6512010B1 (en) * 1996-07-15 2003-01-28 Alza Corporation Formulations for the administration of fluoxetine
JP2001505544A (ja) * 1996-09-11 2001-04-24 ティロッツ・ファルマ・アクチエンゲゼルシャフト フルオシノニド含有経口組成物
JP2002519318A (ja) * 1998-06-26 2002-07-02 エルデイエス・テクノロジーズ・インコーポレーテツド 鼻および肺送達のためのコルチコステロイドを含有する水性組成物
JP2003506462A (ja) * 1999-06-25 2003-02-18 ダーハム ファーマシューティカルズ リミテッド 皮膚浸透剤を含む局所処方物およびその使用
JP2001233772A (ja) * 2000-02-23 2001-08-28 Taiho Yakuhin Kogyo Kk 外用剤組成物
JP2002029965A (ja) * 2000-06-16 2002-01-29 Pacific Corp 親水性または塩の形態よりなる薬物を含有する経皮投与用製剤
JP2007526885A (ja) * 2003-07-07 2007-09-20 ネアーズ エービー マイクロエマルジョンおよび気道疾患を防ぐためのその使用
JP2007533697A (ja) * 2004-04-22 2007-11-22 デュオコート エービー グルココルチコイド救急治療用の医薬組成物
JP2008522997A (ja) * 2004-12-09 2008-07-03 バイエル・ヘルスケア・アクチェンゲゼルシャフト 酸によるグルココルチコイドエステルの安定化
JP2008533052A (ja) * 2005-03-10 2008-08-21 スリーエム イノベイティブ プロパティズ カンパニー 抗ウイルス性組成物および使用方法
JP2009504619A (ja) * 2005-08-11 2009-02-05 ガルデルマ・ソシエテ・アノニム 皮膚科学における局所適用用水中油型エマルション
US20070264344A1 (en) * 2006-03-15 2007-11-15 Galderma S.A. Topically applicable anti-inflammatory O/W emulsions comprising pro-penetrating glycols
JP2010514748A (ja) * 2006-12-29 2010-05-06 アーダナ バイオサイエンス リミテッド 組成物の調製方法
WO2011154004A1 (en) * 2010-06-11 2011-12-15 Leo Pharma A/S A pharmaceutical spray composition comprising a vitamin d analogue and a corticosteroid
WO2013076160A1 (en) * 2011-11-21 2013-05-30 Université Libre de Bruxelles Sustained release formulations useful in the treatment of diseases
CN102940594A (zh) * 2012-12-04 2013-02-27 艾能赛克机械设备(江苏)有限公司 一种头发调理剂

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2021504468A (ja) * 2017-11-27 2021-02-15 ウメクリン コグニチオン アーべー ３α−エチニル−３β−ヒドロキシアンドロスタン−１７−オンオキシムの医薬製剤
JP7314459B2 (ja) 2017-11-27 2023-07-26 ウメクリン コグニチオン アーべー ３α－エチニル－３β－ヒドロキシアンドロスタン－１７－オンオキシムの医薬製剤

Also Published As

Publication number Publication date
US20140357607A1 (en) 2014-12-04
US20190000977A1 (en) 2019-01-03
US20150209429A9 (en) 2015-07-30
EP3003272A1 (en) 2016-04-13
AU2014275195A1 (en) 2015-12-10
WO2014197398A1 (en) 2014-12-11
AR096459A1 (es) 2015-12-30
CA2912873A1 (en) 2014-12-11
CN105263474A (zh) 2016-01-20
HK1223300A1 (zh) 2017-07-28
US10111956B2 (en) 2018-10-30
MX2015016603A (es) 2016-07-28

Similar Documents

Publication Publication Date Title
US10111956B2 (en) Corticosteroid compositions
US20200405733A1 (en) Topical formulations comprising a steroid
AU2015385750B2 (en) Topical corticosteroid compositions
KR101121529B1 (ko) 스테로이드의 경시적 안정성이 개선된 외용 제제
US11179465B2 (en) Topical compositions comprising a corticosteroid
JP2016520656A5 (enExample)
WO2008126076A2 (en) Low-dose mometasone formulations
CA1182048A (en) Topically administrable pharmaceutical compositions containing anti-inflammatory steroids
US6271219B2 (en) Topical formulations comprising skin penetration agents and the use thereof
JP2009029791A (ja) ステロイドを含有するｏ／ｗ型乳化製剤
JP2015193626A (ja) 水中油乳化剤形の医薬組成物及びその製造方法
JP6543945B2 (ja) 乳化組成物
JP2001233772A (ja) 外用剤組成物
JP2016204371A (ja) 皮膚用の医薬組成物
JP2015199729A (ja) 外用医薬組成物
JP2015199730A (ja) 皮膚外用剤の使用性の評価法及び該評価法で使用性に優れると判別される皮膚外用剤

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20170601

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20170601

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20180320

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20180316

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20181016